Mariendistelfrüchte

Milk thistle fruit, the active ingredient in Mariendistelfrüchte, is a herbal supplement presented as an oral preparation for oral use. It is traditionally employed to support normal liver function and antioxidant protection in adult populations.

GNH USA supplies Mariendistelfrüchte as a licensed, GDP‑compliant international pharmaceutical supplier serving pharmacies and clinics worldwide.

Mariendistelfrüchte is used as an herbal product that supports liver‑related pathways and overall antioxidant status.

- Liver health support: helps maintain normal liver function in adults. - Mild elevation of liver enzymes: may assist in normalising enzyme levels during routine monitoring. - Detoxification assistance: provides antioxidant support during periods of increased metabolic stress. - General antioxidant protection: contributes to cellular defence against oxidative damage.

Milk thistle fruit is generally well tolerated, but adverse reactions can occur.

Common Side Effects: - Gastrointestinal discomfort: mild nausea, bloating, or diarrhoea. - Headache: occasional mild headache reported. - Skin irritation: transient rash or itching at the site of contact. - Mild allergic response: occasional urticaria.

Serious or Rare Side Effects: - Severe allergic reaction: anaphylaxis or angioedema requiring immediate medical attention. - Hepatic injury: rare cases of liver function deterioration. - Blood disorders: extremely rare reports of thrombocytopenia.

When considering Mariendistelfrüchte, several safety measures are advisable.

- Pregnancy and breastfeeding: consult a healthcare professional before use. - Pre‑existing liver disease: use under medical supervision. - Concomitant medications: discuss potential interactions with a physician. - Known hypersensitivity: avoid if allergic to milk thistle or related plants. - Store below 25°C: keep in the original pack, protect from moisture.

Milk thistle fruit may influence the activity of certain medicines.

Major Interactions (Avoid): - Cytochrome P450 substrates: may alter metabolism of drugs processed by CYP enzymes. - Anticoagulants/antiplatelet agents: potential increase in bleeding risk.

Moderate Interactions (Monitor Closely): - Statins: possible elevation of liver enzymes. - Diabetes medications: may enhance hypoglycaemic effect. - Other herbal supplements: additive antioxidant or enzyme‑modulating actions.